Chenodeoxycholic acid
|
Basic information |
| Metabolite name | Chenodeoxycholic acid |
 | HMDB0000518 |
 |
C02528 |
 |
10133 |
| Synonyms | Chenodeoxycholate |
| No. of studies | 17 |
|
Basic information |
| Metabolite name | Chenodeoxycholic acid |
| HMDB0000518 |
|
C02528 |
|
10133 |
| Synonyms | Chenodeoxycholate |
| No. of studies | 17 |
|
Relationship between Chenodeoxycholic acid and depression (count: 17) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M007 | Type1 | CRS group vs. control group | Plasma | Wistar rat | Up |
| Study M1143 | Type1 | MDD group vs. control group | Plasma | Human | Down |
| Study M117 | Type1 | CVS group vs. control group | Faece | Wistar rat | Up |
| Study M464 | Type1 | drug-naive MDD group vs. control group | Plasma | Human | Up |
| Study M512 | Type1 | CUMS group vs. control group | Plasma | Goto-Kakizaki rat | Up |
| Study M582 | Type1 | CUMS group vs. control group | Faece | C57BL/6N mouse | Down |
| Study M677 | Type1 | CVS group vs. control group | Faece | Wistar rat | Up |
| Study M677 | Type2 | CVS + Chaihu-Shu-Gan-San group vs. CVS group | Faece | Wistar rat | Down |
| Study M677 | Type2 | CVS + fluoxetine group vs. CVS group | Faece | Wistar rat | Down |
| Study M743 | Type1 | CUS group vs. control group | Plasma | Sprague-Dawley rat | Down |
| Study M774 | Type1 | MDD group vs. control group | Serum | Human | Down |
| Study M787 | Type1 | CRS group vs. control group | Colon | Wistar rat | Down |
| Study M867 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |
| Study M867 | Type2 | CUMS + Baihe-Dihuang Tang group vs. CUMS group | Plasma | Sprague-Dawley rat | Unknown |
| Study M874 | Type1 | ovariectomy group vs. control group | Urine | Sprague-Dawley rat | Up |
| Study M874 | Type2 | ovariectomy + Panax ginseng group vs. ovariectomy group | Urine | Sprague-Dawley rat | Down |
| Study M912 | Type1 | CUMS group vs. control group | Serum | ICR mouse | Up |
| Study M928 | Type1 | CUMS group vs. control group | Faece | C57BL/6 mouse | Down |
| Study M947 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |
| Study M947 | Type2 | CUMS + middle dose of Chaigui granules group vs. CUMS group | Plasma | Sprague-Dawley rat | Down |
| Study M947 | Type2 | CUMS + high dose of Chaigui granules group vs. CUMS group | Plasma | Sprague-Dawley rat | Down |
| Study M953 | Type1 | CRS group vs. control group | Faece | Sprague-Dawley rat | Up |
| Study M953 | Type2 | CRS + Shugan Granule group vs. CRS group | Faece | Sprague-Dawley rat | Up |
| Study M958 | Type4 | remitter group vs. non-remitter group, at baseline | Serum | Human | Up |